MedPath

Cervical dystonia, confirming the discriminative value of a new diagnostic method

Completed
Conditions
cervical dystonia
spasmodic torticollis
wry neck
10028037
Registration Number
NL-OMON40531
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

Patients with idiopatic cervical dystonia
Age of onset *26
botulinum toxin treatment naive or last treatment more then 3 months ago
Informed consent

Exclusion Criteria

Fixed dystonia (often considered a sign of psychogenic torticollis)
Secondary dystonia
Use of neuropharmaceuticals
Pregnancy

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The accuracy of the new method in muscle selection. The accuracy will be<br /><br>calculated using the diagnostic odds ratio, sensitivity and specificity. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>The differences in characteristics and distribution of abnormal activation<br /><br>patterns between CD patients and FT patients .<br /><br><br /><br>Additional outcome in CD patients that are currently receiving BTX treatment:<br /><br>The differences in characteristics and prevalence of abnormal activation<br /><br>patterns before and after botulinum toxin treatment.</p><br>
© Copyright 2025. All Rights Reserved by MedPath